Loading…
Envista Holdings Corporation is projected to rise to $29.29 by 2027, a +14% move from its current price of $25.76. NVST is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $25.31 | $25.77 | $26.25 | +0.04% |
| Jul 13 | $25.13 | $25.78 | $26.46 | +0.09% |
| Jul 14 | $24.99 | $25.79 | $26.62 | +0.13% |
| Jul 15 | $24.88 | $25.80 | $26.76 | +0.17% |
| Jul 16 | $24.78 | $25.82 | $26.89 | +0.22% |
| Jul 17 | $24.70 | $25.83 | $27.01 | +0.26% |
| Jul 18 | $24.62 | $25.84 | $27.12 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.62 | $25.84 | $27.12 | +0.30% |
| Week 2 | $24.21 | $25.92 | $27.75 | +0.61% |
| Week 3 | $23.91 | $26.00 | $28.26 | +0.92% |
| Week 4 | $23.68 | $26.07 | $28.72 | +1.22% |
| Week 5 | $23.48 | $26.15 | $29.13 | +1.53% |
| Week 6 | $23.31 | $26.23 | $29.52 | +1.84% |
| Week 7 | $23.16 | $26.31 | $29.90 | +2.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands.
The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Envista Holdings Corporation (NVST) is a healthcare stock trading at $25.91 with a market cap of $4.22B, and it is ranked 1496. The current price reflects the latest market valuation and place in the market ranking.
Near term, the forecast suggests a neutral path for 2026 with an average price of $25.91 and a range from $21.69 to $32.64, alongside a neutral sentiment and an ROI of 0.
Looking further ahead, the multi-year forecast shows a bullish trajectory, with the average price rising through 2027–2050 and escalating ROI, notably reaching $38.51 in 2030 with a 48.6 ROI, then $96.19 in 2040 (271.2 ROI) and $182.46 in 2050 (604.2 ROI).
A major floor 22.0% below — a decisive break under it would weaken the trend.
The nearest floor, 13.0% below — buyers have tended to step in here.
The nearest ceiling, 7.3% above — a clean break opens room to run.
A major ceiling 18.6% above — clearing it would confirm fresh momentum.
Key NVST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NVST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $26.41 | Sell | $26.22 | Sell |
| MA 10 | $26.72 | Sell | $26.32 | Sell |
| MA 20 | $26.00 | Sell | $25.95 | Sell |
| MA 50 | $24.86 | Buy | $25.45 | Buy |
| MA 100 | $25.87 | Sell | $25.12 | Buy |
| MA 200 | $23.84 | Buy | $24.08 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.59 | Neutral |
| Stoch RSI (14) | 7.23 | Buy |
| CCI (20) | -6.80 | Neutral |
| Williams %R (14) | -72.57 | Info |
| MACD (12,26,9) | -0.09 | Sell |
| ROC (12) | 2.57 | Buy |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 27.43 | Neutral |
| TRIX (15) | 0.37 | Buy |
| Awesome (5,34) | 1.47 | Buy |
| Ultimate (7,14,28) | 47.62 | Neutral |
| Momentum (10) | -0.73 | Sell |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 25.72 | Buy |
| ADX (14) | 20.83 | Buy |
| ATR (14) | 0.43 | Info |
The 30-day technical picture is bullish on NVST, with RSI14 at 70, suggesting upside momentum.
The 50-day simple moving average (SMA) is $25.02 and the 200-day SMA is $23.46, indicating a near-term bullish tilt as the price sits above both averages. Support is at $22.40 and resistance at $25.91, framing a tight near-term map. The 30-day range runs from $23.09 to $29.08, and annualized volatility is 30%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $21.69 | $25.76 | $32.90 | 0% | Neutral | |
| $23.98 | $29.29 | $37.39 | +14% | Neutral | |
| $25.23 | $31.38 | $41.15 | +22% | Bullish | |
| $27.69 | $34.98 | $46.84 | +36% | Bullish | |
| $29.84 | $38.20 | $52.08 | +48% | Bullish | |
| $34.78 | $45.07 | $62.41 | +75% | Bullish | |
| $40.92 | $53.62 | $75.31 | +108% | Bullish | |
| $41.38 | $54.79 | $77.95 | +113% | Bullish | |
| $42.40 | $56.71 | $81.64 | +120% | Bullish | |
| $45.65 | $61.63 | $89.71 | +139% | Bullish | |
| $68.51 | $96.47 | $147.15 | +274% | Bullish | |
| $125.10 | $188.94 | $308.93 | +633% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $21.69 | $25.76 | $31.04 | +0.00% |
| August 2026 | $23.07 | $27.00 | $32.30 | +4.82% |
| September 2026 | $22.78 | $26.80 | $32.31 | -0.75% |
| October 2026 | $22.38 | $26.43 | $32.07 | -1.38% |
| November 2026 | $22.59 | $26.77 | $32.66 | +1.30% |
| December 2026 | $22.57 | $26.83 | $32.90 | +0.22% |
Click any year to see its month-by-month NVST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NVST is projected to trade between $21.69 and $32.90, averaging $25.76 — a potential gain of 0% from today's $25.76. Price action looks broadly range-bound.
Envista Holdings Corporation's 2027 outlook centres on $29.29, within a $23.98 to $37.39 range. That is up +14% on the projected 2026 average. That marks a +14% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, NVST could reach as high as $41.15, with a base case around $31.38 and support toward $25.23 — roughly +22% from $25.76. Momentum favours further upside here.
Expect NVST to range from $27.69 to $46.84 through 2029. The $34.98 average target implies a +36% move from current prices. That is up +11% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The NVST price prediction for 2030 points to an average of $38.20 (low $29.84, high $52.08) — a potential gain of +48% on today's $25.76. Momentum favours further upside here.
In 2031, NVST is projected to trade between $34.78 and $62.41, averaging $45.07 — a potential gain of +75% from today's $25.76. That is up +18% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Envista Holdings Corporation's 2032 outlook centres on $53.62, within a $40.92 to $75.31 range. That is up +19% on the projected 2031 average. That marks a +108% change versus current levels. Momentum favours further upside here.
By 2033, NVST could reach as high as $77.95, with a base case around $54.79 and support toward $41.38 — roughly +113% from $25.76. Buyers look set to stay in control over this stretch.
Expect NVST to range from $42.40 to $81.64 through 2034. The $56.71 average target implies a +120% move from current prices. That is up +4% on the projected 2033 average. Momentum favours further upside here.
The NVST price prediction for 2035 points to an average of $61.63 (low $45.65, high $89.71) — a potential gain of +139% on today's $25.76. Buyers look set to stay in control over this stretch.
In 2040, NVST is projected to trade between $68.51 and $147.15, averaging $96.47 — a potential gain of +274% from today's $25.76. That is up +57% on the projected 2035 average. Momentum favours further upside here.
Envista Holdings Corporation's 2050 outlook centres on $188.94, within a $125.10 to $308.93 range. That is up +96% on the projected 2040 average. That marks a +633% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NVST today (≈ 38.819876 NVST) could be worth
$7,334.47
+$6,334.47 (+633%) by 2050 · US Dollar
Based on the average projected NVST price of $188.94 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NVSTwould be worth at today's price.
$1,000 invested in NVST on Jul 10, 2025 (≈ 48.26255 NVST) would be worth
$1,243.24
+$243.24 (+24.3%) today · 1.24× · US Dollar
Based on a NVST entry price of $20.72 vs. today's $25.76.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $27.63 | $932.32 | -6.8% |
| 1 month ago | $24.06 | $1,070.66 | +7.1% |
| 3 months ago | $26.39 | $976.13 | -2.4% |
| 6 months ago | $23.38 | $1,101.8 | +10.2% |
| 1 year ago | $20.72 | $1,243.24 | +24.3% |
| All time (5.0y) ago | $44.09 | $584.26 | -41.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NVST forecast.
Our base-case forecast reaches $52.00 around 2032.
Implied market cap at $52.00: $8.46B
The multi-year forecast shows a steadily rising average price with bullish sentiment from 2027 onward. 2027 shows an average of $29.70 with a 14.6 ROI, followed by 2028 at $32.13 (ROI 24), 2029 at $34.18 (ROI 31.9), and 2030 at $38.51 (ROI 48.6).
From 2031 to 2035, averages climb to $45.93, $52.72, $54.69, $56.58, and $60.47 respectively, with ROIs of 77.3, 103.5, 111.1, 118.4, and 133.4. The long-horizon view extends to 2040 with an average of $96.19 (ROI 271.2) and to 2050 with an average of $182.46 (ROI 604.2), both in bullish territory. These figures are estimates and not guarantees; actual results may differ.
Tap a question to reveal the answer.
2030 min $30.06, avg $38.51, max $52.55; ROI 48.6. The forecast shows an average price of $38.51 with a range from $30.06 to $52.55 and an ROI of 48.6.
The forecast shows a neutral stance in 2026 and a bullish trajectory from 2028 onward, with 2027 avg $29.70 (ROI 14.6) and higher averages in subsequent years, culminating in larger ROIs by 2030 (48.6) and beyond. These are estimates, not guarantees.
Yes, the forecast for 2035 lists an average price of $60.47 with a min of $44.76 and a max of $88.08, and an ROI of 133.4.
RSI14 is 70, indicating bullish momentum. The 50-day SMA is $25.02 and the 200-day SMA is $23.46. Support sits at $22.40 and resistance at $25.91; the 30-day range is $23.09 to $29.08, with annualized volatility at 30%.
Current price is $25.91 and market cap is $4.22B. The stock is ranked 1496.
Envista Holdings Corporation Community Discussion
0Share your Envista Holdings Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.